68 related articles for article (PubMed ID: 23447486)
1. [Cox model analysis of curative effect and prognostic factors of oral robot-assisted RPLN dissection for head and neck malignancies].
Ding TR; Julaiti T; Yao ZT; Maimaitituxun T
Shanghai Kou Qiang Yi Xue; 2023 Oct; 32(5):508-512. PubMed ID: 38171521
[TBL] [Abstract][Full Text] [Related]
2. Impact of smoking on pathological features in oral cavity squamous cell carcinoma.
Al Feghali KA; Ghanem AI; Burmeister C; Chang SS; Ghanem T; Keller C; Siddiqui F
J Cancer Res Ther; 2019; 15(3):582-588. PubMed ID: 31169224
[TBL] [Abstract][Full Text] [Related]
3. High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.
Téllez-Gabriel M; Arroyo-Solera I; León X; Gallardo A; López M; Céspedes MV; Casanova I; López-Pousa A; Quer M; Mangues MA; Barnadas A; Mangues R; Pavón MA
Cancer Med; 2013 Dec; 2(6):950-63. PubMed ID: 24403269
[TBL] [Abstract][Full Text] [Related]
4. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
5. The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.
Wang D; Müller S; Amin AR; Huang D; Su L; Hu Z; Rahman MA; Nannapaneni S; Koenig L; Chen Z; Tighiouart M; Shin DM; Chen ZG
Clin Cancer Res; 2012 Sep; 18(17):4589-99. PubMed ID: 22829201
[TBL] [Abstract][Full Text] [Related]
6. Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality.
Buryska S; Patel K; Wuertz B; Gaffney PM; Ondrey F
Anticancer Res; 2023 Dec; 43(12):5299-5310. PubMed ID: 38030164
[TBL] [Abstract][Full Text] [Related]
7. Results of surgical treatment of lymph node metastases in patients with cutaneous squamous cell carcinoma of the head and neck.
León X; López S; Pérez M; Valero C; Holgado A; Quer M; Vega C
Acta Otorrinolaringol Esp (Engl Ed); 2024 Jan; ():. PubMed ID: 38224869
[TBL] [Abstract][Full Text] [Related]
8. Family history of cancer and head and neck cancer survival.
Getz KR; Rozek LS; Peterson LA; Bellile EL; Taylor JMG; Wolf GT; Mondul AM
Laryngoscope; 2017 Aug; 127(8):1816-1820. PubMed ID: 28266024
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer: an evolving treatment paradigm.
Cognetti DM; Weber RS; Lai SY
Cancer; 2008 Oct; 113(7 Suppl):1911-32. PubMed ID: 18798532
[TBL] [Abstract][Full Text] [Related]
10. Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt.
Flukes S; Long S; Lohia S; Barker CA; Dunn LA; Cracchiolo J; Ganly I; Patel S; Cohen MA
OTO Open; 2021; 5(1):2473974X20984720. PubMed ID: 33474523
[TBL] [Abstract][Full Text] [Related]
11. Platysma Sign: A Feature of Extra-capsular Spread.
Mukherjee R; Roychowdhury A; Guha S
Indian J Surg Oncol; 2023 Dec; 14(4):907-908. PubMed ID: 38187859
[TBL] [Abstract][Full Text] [Related]
12. Extra-Capsular Spread of Lymph Node Metastasis in Oral, Oropharyngeal and Hypopharyngeal Cancer: A Comparative Subsite Analysis.
Kang YJ; Park G; Park SY; Kim T; Kim E; Heo Y; Lee C; Jeong HS
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339410
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
Hanna DL; Loupakis F; Yang D; Cremolini C; Schirripa M; Li M; Matsusaka S; Berger MD; Miyamoto Y; Zhang W; Ning Y; Antoniotti C; Salvatore L; Moran M; Zeger G; Astrow SH; Falcone A; Lenz HJ
Clin Colorectal Cancer; 2018 Sep; 17(3):e471-e488. PubMed ID: 29636300
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?
Bhatt RS; Atkins MB
Clin Cancer Res; 2014 Jun; 20(11):2838-45. PubMed ID: 24714770
[TBL] [Abstract][Full Text] [Related]
16. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
17. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
